Abstract:
A device including a first plate configured to interface with a first bone structure of a joint; a second plate configured to interface with a second bone structure of the joint opposite the first bone structure; and at least one mechanical actuation mechanism disposed between the first plate and the second plate and configured to apply a distraction force along an axis between the first plate and the second plate so as to urge the first plate and the second plate away from one another, wherein the device is configured so as to have a range of motion ranging from a minimum distance between the first plate and the second plate to a maximum distance between the first plate and the second plate, and wherein the mechanical actuation mechanism is configured such that the distraction force is substantially constant distraction force across the range of motion.
Abstract:
A system and method may be used to evaluate soft tissue. A hip joint evaluation may use an adjustable spacer, such as varying sized physical spacers or an inflatable bladder, along with a sensor to measure force, pressure, gap distance, or the like, for example during a range of motion test. A method may include using a maximum pressure during the range of motion test to determine a maximum pressure during the range of motion test. The maximum pressure may be output for display on a user interface.
Abstract:
A device including first plate configured to interface with a first bone structure of a joint; a second plate configured to interface with a second bone structure of the joint; and at least one mechanical actuation mechanism disposed between the first plate and the second plate and configured to apply a distraction force so as to urge the first and second plates away from one another, wherein the at least one mechanical actuation mechanism includes first and second actuation sub-mechanisms configured to provide first actuation and second sub-mechanism distraction forces that are antagonist to one another; wherein the device has a range of expansion ranging from a minimum distance to a maximum distance between the first plate and the second plate, and wherein the first actuation sub-mechanism distraction force and the second actuation sub-mechanism distraction force combine to provide the distraction force that is substantially constant.
Abstract:
A device including a first plate configured to interface with a first bone structure of a joint; a second plate configured to interface with a second bone structure of the joint opposite the first bone structure; and at least one mechanical actuation mechanism disposed between the first plate and the second plate and configured to apply a distraction force along an axis between the first plate and the second plate so as to urge the first plate and the second plate away from one another, wherein the device is configured so as to have a range of motion ranging from a minimum distance between the first plate and the second plate to a maximum distance between the first plate and the second plate, and wherein the mechanical actuation mechanism is configured such that the distraction force is substantially constant distraction force across the range of motion.
Abstract:
A drug-eluting spacer for temporary implantation in a knee joint includes a femoral component configured to interface with a femur, a tibial tray component having an upper surface, a lower surface, and a shaft extending from the lower surface, the shaft configured to be positioned axially within a tibia, the lower surface configured to interface with the tibia, and a tibial insert component having an upper surface and a lower surface, the lower surface of the tibial insert component configured to engage the upper surface of the tibial tray component, the upper surface of the tibial insert component configured to receive the femoral component in an articulating manner. The femoral component, the tibial tray component, and the tibial insert component carry joint loads when implanted. The drug-eluting spacer is configured to elute a biologically active agent in an amount effective to treat an infection of the knee joint.
Abstract:
A system includes a patella trial comprising a baseplate and an articular surface member configured to move along at least one of a medial-lateral axis or a superior-inferior axis of the baseplate; and an implant comprising a posterior articular surface and an anterior surface, wherein the anterior surface has a medial/lateral width with a midpoint, wherein the posterior articular surface has a posterior-most point, wherein an imaginary line extending through the posterior-most point is parallel to an imaginary line extending through the midpoint, and wherein a distance (I) is defined by measuring a length between the imaginary line extending through the posterior-most point and the imaginary line extending through the midpoint; wherein the implant is selected from a set of implants each having a different I, and wherein the chosen implant is selected based on an offset of the articular surface member relative to the baseplate on the patella trial.
Abstract:
Various embodiments of the present invention relate to an apparatus and method for reverse shoulder arthroplasty (e.g., reverse total shoulder arthroplasty). In one specific example, a glenoid component used to resurface the scapula may be provided. Of note, unlike traditional total shoulder arthroplasty the glenoid component in a reverse shoulder is convex rather than concave; it acts as a physical stop to prevent the superior migration of the humeral head—a typical occurrence in patients suffering from rotator cuff tear arthropathy (CTA).
Abstract:
Various embodiments of the present invention relate to an apparatus and method for reverse shoulder arthroplasty (e.g., reverse total shoulder arthroplasty). In one specific example, a glenoid component used to resurface the scapula may be provided. Of note, unlike traditional total shoulder arthroplasty the glenoid component in a reverse shoulder is convex rather than concave; it acts as a physical stop to prevent the superior migration of the humeral head—a typical occurrence in patients suffering from rotator cuff tear arthropathy (CTA).
Abstract:
Disclosed herein is a kit that includes a humeral stem having a central longitudinal axis, the humeral stem configured to attach to a resected bone; a first tuberosity component having a first thickness relative to the central longitudinal axis of the humeral stem; a second tuberosity component having a second thickness relative to the central longitudinal axis of the humeral stem, wherein the first thickness of the first tuberosity component is different than the second thickness of the second tuberosity component; and at least one proximal segment configured to engage at least one of the first tuberosity component and the second tuberosity component. In an embodiment, the first thickness of the first tuberosity component is at least 20 mm relative to the central axis of the humeral stem, and the second thickness of the second tuberosity component is at least 20 mm relative to the central axis of the humeral stem.
Abstract:
Methods, systems, devices and tools for placing bone stabilization components in a patient are provided. The systems and devices have a reduced number of discrete components that allow placement through small incisions and tubes. More particularly, the present invention is directed to screws for use in systems and methods of treating the spine, which eliminate pain and enable spinal motion, which effectively mimics that of a normally functioning spine. Methods are also provided for installation of the screw and other subject systems.